We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCAX
276
Bicara Therapeutics
BCAX
$1.53B
$11.1M 0.05%
373,380
+134,558
+56% +$3M
DOV icon
277
Dover
DOV
$26B
$11.1M 0.05%
49,381
-2,833
-5% -$617K
ITT icon
278
ITT
ITT
$18.3B
$11M 0.05%
55,724
+7,630
+16% +$1.54M
TENX icon
279
Tenax Therapeutics
TENX
$72.6M
$10.9M 0.05%
+749,588
New +$9.58M
AVT icon
280
Avnet
AVT
$7.56B
$10.9M 0.05%
122,346
+72,914
+148% +$5.96M
SHOP icon
281
Shopify
SHOP
$187B
$10.8M 0.05%
94,634
-754
-0.8% -$86K
DXCM icon
282
DexCom
DXCM
$33.2B
$10.8M 0.05%
160,272
+77,680
+94% +$5.18M
PFG icon
283
Principal Financial Group
PFG
$25B
$10.7M 0.05%
99,698
+85,521
+603% +$8.68M
DAR icon
284
Darling Ingredients
DAR
$10.3B
$10.7M 0.05%
195,662
+52,470
+37% +$3.13M
APGE
285
DELISTED
Apogee Therapeutics
APGE
$10.6M 0.05%
79,684
-143,857
-64% -$13M
MET icon
286
MetLife
MET
$62B
$10.5M 0.05%
124,680
-5,265
-4% -$425K
STT icon
287
State Street
STT
$53.4B
$10.5M 0.05%
61,965
+9,764
+19% +$1.51M
CNC icon
288
Centene
CNC
$33.1B
$10.4M 0.05%
162,675
+127,886
+368% +$6.84M
BE icon
289
Bloom Energy
BE
$74.5B
$10.3M 0.05%
34,094
+17,772
+109% +$4.55M
UPS icon
290
United Parcel Service
UPS
$87B
$10.3M 0.05%
95,685
+4,670
+5% +$485K
SION
291
Sionna Therapeutics
SION
$325M
$10.2M 0.05%
233,208
-3,605
-2% -$144K
FDX icon
292
FedEx
FDX
$76.3B
$9.79M 0.04%
31,285
+8,513
+37% +$3.09M
WAT icon
293
Waters Corp
WAT
$40.2B
$9.64M 0.04%
25,725
-41
-0.2% -$14K
OLMA icon
294
Olema Pharmaceuticals
OLMA
$941M
$9.39M 0.04%
751,133
-8,380
-1% -$112K
COP icon
295
ConocoPhillips
COP
$161B
$9.18M 0.04%
88,410
+128
+0.1% +$15.2K
NRIX icon
296
Nurix Therapeutics
NRIX
$2.71B
$9.16M 0.04%
377,902
-156,357
-29% -$2.66M
MCY icon
297
Mercury Insurance
MCY
$5.79B
$9.06M 0.04%
85,045
+18,271
+27% +$1.8M
MRSH
298
Marsh
MRSH
$88.6B
$9.02M 0.04%
54,152
+2,561
+5% +$428K
ALLO icon
299
Allogene Therapeutics
ALLO
$681M
$9.01M 0.04%
4,336,296
+1,338,978
+45% +$2.94M
OCUL icon
300
Ocular Therapeutix
OCUL
$2.34B
$8.91M 0.04%
907,839
-41,377
-4% -$375K
10 11
12
13 14

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.